Prof. Johannes Khinast, CEO and scientific director, and Dr. Thomas Klein, CEO and business director of the Research Center Pharmaceutical Engineering, or RCPE, the world’s first pharmaceutical engineering company that combines simulation, formulation and processing for large international companies such as Pfizer, Bayer and Novartis, give an overview of the foundation of the center and its growth, as well as provide an in-depth analysis of how their revolutionary approach will assist current and potential partners to consistently produce high-quality products.
As Business Director and co-founder, could you introduce the Research Center Pharmaceutical Engineering (RCPE) to our international readers?
"Austria is very science-oriented and industry-friendly, and notably, an ideal place for new company locations and start-ups."
